Navigation Links
Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor
Date:11/13/2007

e. The tax credit that Nunez promised would have applied to families making from 300% to 450% of the federal poverty level, starting at $62,000 annual income for a family of four.

The special session bill, AB 1X1, is a false promise unless it states clearly that the individual mandate will not go into effect unless the ballot measure providing funding is passed, said FTCR. Even low-income families will not get the subsidized coverage they are promised if the insurance industry mounts a multimillion-dollar campaign to defeat a ballot initiative containing the bill's funding.

"The current compromise bill is so sloppy and lacking in key information that a Legislature under pressure just to do something risks a disastrous mistake," said Jerry Flanagan, health policy director of FTCR. "At this point, lawmakers should take the strong first step of insuring more children, and leave the rest of this dangerously hasty plan for next year."

FTCR's analysis of the bill found numerous significant errors and omissions:

-- Affordability --- no middle-class tax credit. It was widely reported that middle-income individuals forced to buy coverage would receive a tax credit for the portion of premium costs that exceed 5% of their incomes, but the provision of that tax credit appears to be missing from the new bill.

-- Affordability -- Funding contingency. If a middle-class tax credit is to be left to an ensuing ballot measure, and the ballot measure does not pass, it appears the individual mandate could still be put into effect.

-- Guaranteed issue -- but no real guarantee? AB 1X1 calls for guaranteed issue of private insurance to all comers. Yet a related bill, Assemblyman Dymally's AB1X3, appears to allow insurers the option of refusing to offer coverage to whomever they choose. AB 1X3 was reportedly pulled from the schedule for Wednesday's hearing late Tuesday night, but this section of Dymally's measure, or similar exclusions in Nunez's AB
'/>"/>

SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise
2. Hospitals Agree to Pay Fees in Exchange for More Income, but Consumers in the Dark About What Theyll be Charged Under Nunez Plan
3. Nunez and Legislators Urged to Oppose Mandatory Purchase of Private Health Insurance
4. The Good, the Bad, and the Ugly of the Nunez/Perata Health Plan
5. Penn study finds pro-death proteins required to regulate healthy immune function
6. UCLA researchers identify markers that may predict diabetes in still-healthy people
7. Air pollution linked to cardiovascular risk indices in healthy young adults
8. More proof needed of safety and quality of electronic personal health records
9. Health care incentive model offers collaborative approach
10. Loneliness is bad for your health
11. Mailman School of Public Health study examines link between racial discrimination and substance use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... Research Hospital have demonstrated a more effect...fluenza. They found that the antibiotics clindamyc...ting their protein synthesis, are more effective t...-lactam" antibiotic ampicillin, which causes the b...portant because pneumonia, rather than the influen...
(Date:1/8/2009)...2009 Continues Growth Trend , , NORTH HOLLYWOOD... Hospitalist Company, Inc. (Nasdaq: IPCM ), a le...e company, announced today that it has acquired th...ltants, Inc. (MACC) in St. Louis, Missouri. The ac.... Louis market, where IPC has established a signif...
(Date:1/8/2009)...ire-USNewswire/ -- A new educational Web site offe...gs, biological products and medical devices from t...nters for Education and Research on Therapeutics (... a dozen leading research centers nationwide. The...twork ( CHAIN ) http://www.chainonline.org links...
(Date:1/8/2009)...ness continues to drive overall performance , ,...oration (ZixCorp(R)), (Nasdaq: ZIXI ), the leade...escribing, today offered a corporate update by its...nded the year on a high note in our Email Encrypti...he year in the fourth quarter," said Spurr. "Our ...
Breaking Medicine News(10 mins):Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:IPC The Hospitalist Company Acquires Missouri Practice Group 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4
...shed yesterday looks into support props for care g... elucidates the plight of most relatives // and ca...ften the rehabilitation and restoration of confide... realms of hospital in –patient care. It is the v...
...sions for breast cancer fell by a third between 19...ncy for Healthcare Research and Quality. The decli...cilities for breast cancer surgeries, plus the gro...ns such as lumpectomies, which are typically perfo...
...survivors will be able to do away with invasive br...ch involving stem cells //extracted from their own... who are investigating the potential these cells m.... In animal models, the researchers hope to prove...
...hyam Sarda, a prime accused in the expired blood t...nior police official.// "We have arrested Ghanshy...uced in court," said Gyanwant Singh, deputy commis... department). Ghanshyam's brother, Govind Sarda,...
Other Medicine News:Health News:Breast reconstruction may be possible with fat stem cells 2
(Date:1/8/2009)..., CHICAGO, Jan. 8 If you are t... today, you,re not alone. Half of the people takin...ed. The reasons are,varied -- they forget, are bu...ision not to. Noncompliance has been called the Ac...on General Everett Koop commented, "Drugs don,t,w...
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire/ -...hat predict a high likelihood of relapse in childr...gh the researchers caution that further research i...led IKZF1 or IKAROS, lead to leukemia relapse,...future diagnostic tests to assess the risk of trea...
(Date:1/7/2009)..., BEIJING, Jan. 7 Tiantan Puhua Ho...ua.com ), the worldwide leader in using stem cells...unced today six new globally experienced additions...tly expand the hospital,s treatment capabilities f...nts. The six senior doctors include the distinguis...
(Date:1/6/2009)..., COMMACK, N.Y., Jan. 6 In recent ...r, University of Memphis , scientists found that ...n(R), is the first and only proven ingredient to i...hereby increasing blood nitrate/nitrate (NOx) in h...ilator and enables an increase in blood flow to th...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Cats Can Trigger Eczema in Some Infants 22745 1Cats Can Trigger Eczema in Some Infants 22745 2Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 22742 1Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 22742 2Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 22742 3Cynosure Expands Presence in China with the Opening of Sales Office in Beijing 22739 1Cynosure Expands Presence in China with the Opening of Sales Office in Beijing 22739 2INSPIRIS Acquires Care Level Management 22736 1INSPIRIS Acquires Care Level Management 22736 2
...e Response or Reduction of,Lesion Size by More tha...PRNewswire-FirstCall/ - Nventa,Biopharmaceuticals ...sitive results from a clinical trial examining the...vestigational therapeutic,vaccine for human papill... highest grade of cervical dysplasia (CIN III). Th...
...07 - Accentia,Biopharmaceuticals, Inc. (NASDAQ: AB... of the American Academy of Allergy, Asthma, and,I..., CA. The,posters discussed findings from a survey... the U.S., U.K., France, and Germany on the,burden...tudes of,the fungal etiology of CS, and the differ...
Other Medicine Technology:Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
The Proteineer suite integrates powerful mass spectrometers with robotics and bioinformatics to deliver maximum productivity in high-throughput proteomics.
The ProteomeLab PA 800 resolves and quantifies proteins by their isoelectric point and molecular weight, generates high-resolution peptide maps and carbohydrate profiles and provides front-end separa
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110.
Medicine Products: